Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Stanford Engineering & Russ Altman and Stanford Engineering. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stanford Engineering & Russ Altman and Stanford Engineering or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The future of cancer neuroscience

31:13
 
Share
 

Manage episode 500436417 series 2712286
Content provided by Stanford Engineering & Russ Altman and Stanford Engineering. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stanford Engineering & Russ Altman and Stanford Engineering or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Neurologist Michelle Monje studies the close relationship between cancer and the nervous system, particularly in an aggressive brain cancer that often strikes in childhood. Her research shows that the cancer cells are electrically integrated into the brain itself and these connections actually help the cancer to grow. Monje and collaborators have now developed an immunotherapy that has shown great promise in mice and early human trials. One patient had a “complete response” and is cancer-free four years after treatment, Monje tells host Russ Altman on this episode of Stanford Engineering’s The Future of Everything podcast.

Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to [email protected].

Episode Reference Links:

Connect With Us:

Chapters:

(00:00:00) Introduction

Russ Altman introduces guest Michelle Monje, a professor of pediatric neurology at Stanford University.

(00:03:39) Focus on Cancer Research

Monje’s clinical observations led to exploring cancer-neuron interactions.

(00:05:28) Neurons and Glial Cells

The role of neurons and glial cells in brain function and disease.

(00:08:32) Gliomas in Children

An overview of gliomas and their origins in glial precursor cells.

(00:10:12) Rethinking Brain Cancer Behavior

How gliomas don’t just grow—they integrate with brain circuits.

(00:14:49) Mechanisms of Tumor Growth

Two primary mechanisms by which cancer exploits the nervous system.

(00:16:32) Synaptic Integration of Cancer Cells

The discovery that glioma cells form synapses with neurons.

(00:20:06) CAR T-Cell Therapy

Adapting CAR T-cell immunotherapy to target brain tumors.

(00:22:52) Targeting GD2 Antigen

Identification of a surface marker enables precision CAR T-cell therapy.

(00:24:35) Immune Access to the Brain

The ability of CAR T-cells to reach the brain, despite prior understanding.

(00:26:16) First Clinical Trial Results

The significant tumor reduction and response from CAR T-cell therapy.

(00:28:21) Combined Therapies

Pairing immune therapy with neural signaling blockers for better outcomes.

(00:30:35) Conclusion

Connect With Us:

Episode Transcripts >>> The Future of Everything Website

Connect with Russ >>> Threads / Bluesky / Mastodon

Connect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  continue reading

346 episodes

Artwork
iconShare
 
Manage episode 500436417 series 2712286
Content provided by Stanford Engineering & Russ Altman and Stanford Engineering. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stanford Engineering & Russ Altman and Stanford Engineering or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Neurologist Michelle Monje studies the close relationship between cancer and the nervous system, particularly in an aggressive brain cancer that often strikes in childhood. Her research shows that the cancer cells are electrically integrated into the brain itself and these connections actually help the cancer to grow. Monje and collaborators have now developed an immunotherapy that has shown great promise in mice and early human trials. One patient had a “complete response” and is cancer-free four years after treatment, Monje tells host Russ Altman on this episode of Stanford Engineering’s The Future of Everything podcast.

Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to [email protected].

Episode Reference Links:

Connect With Us:

Chapters:

(00:00:00) Introduction

Russ Altman introduces guest Michelle Monje, a professor of pediatric neurology at Stanford University.

(00:03:39) Focus on Cancer Research

Monje’s clinical observations led to exploring cancer-neuron interactions.

(00:05:28) Neurons and Glial Cells

The role of neurons and glial cells in brain function and disease.

(00:08:32) Gliomas in Children

An overview of gliomas and their origins in glial precursor cells.

(00:10:12) Rethinking Brain Cancer Behavior

How gliomas don’t just grow—they integrate with brain circuits.

(00:14:49) Mechanisms of Tumor Growth

Two primary mechanisms by which cancer exploits the nervous system.

(00:16:32) Synaptic Integration of Cancer Cells

The discovery that glioma cells form synapses with neurons.

(00:20:06) CAR T-Cell Therapy

Adapting CAR T-cell immunotherapy to target brain tumors.

(00:22:52) Targeting GD2 Antigen

Identification of a surface marker enables precision CAR T-cell therapy.

(00:24:35) Immune Access to the Brain

The ability of CAR T-cells to reach the brain, despite prior understanding.

(00:26:16) First Clinical Trial Results

The significant tumor reduction and response from CAR T-cell therapy.

(00:28:21) Combined Therapies

Pairing immune therapy with neural signaling blockers for better outcomes.

(00:30:35) Conclusion

Connect With Us:

Episode Transcripts >>> The Future of Everything Website

Connect with Russ >>> Threads / Bluesky / Mastodon

Connect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  continue reading

346 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play